Róbert Babeľa
Róbert Babeľa is a specialist in the field of health technology assessment, which he has been working on for more than a decade. He is a graduate of three universities including the Open University Business School, London, UK and the University of Sheffield, Sheffield, UK. He is the author and co-author of more than 180 publications at home and abroad, and has gained practical skills during his more than 20 years in various positions in the healthcare sector, where he continues to work. Prof. PhDr. Róbert Babeľa, PhD., MBA, MSc (HTA), FISAC is a member of several editorial boards of international journals and professional companies. He currently focuses on scientific projects related to the quantification of the actual total costs of selected diagnoses or medical fields in Slovakia under the auspices of the Biomedical Center of the Slovak Academy of Sciences and evaluates the cost-effectiveness of selected screenings in oncology for the National Cancer Institute.
-
Discussion
Discussion of invited guests:
Adam Kozierkiewicz, JASPERS, European Investment Bank
Róbert Babeľa, Ústav zdravotníckych disciplín VŠZaSP sv. Alžbety
Jozef Benčík, SAS Slovakia
Daren Wilson, Roche Slovakia
Videorecord
-
Data economics in healthcare: examples from selected therapeutics areas
The data economy in healthcare is closely linked to economic assessments in healthcare, which are increasingly being used outside the field of drug policy. Economic assessments in health care are de facto one part of the economy that deals with the efficiency, cost, value and behavior of the various components of the healthcare delivery system, especially in terms of resource consumption. In our short presentation, we will look at how the data economy - namely the direct and indirect costs of the selected diagnosis consumed - can influence the decision-making process in the healthcare delivery system from the perspective of key stakeholders.
-
Chairman introduction speech
-
Cost Data in Healthcare